Literature DB >> 2436655

Characterization of the omega-conotoxin target. Evidence for tissue-specific heterogeneity in calcium channel types.

L J Cruz, D S Johnson, B M Olivera.   

Abstract

omega-Conotoxin GVIA (omega-CgTx-VIA) is a 27 amino acid peptide from the venom of the fish-hunting snail, Conus geographus, that blocks voltage-activated Ca channels. The characterization of a biologically active, homogeneous 125I-labeled monoiodinated Tyr22 derivative of omega-conotoxin GVIA and its use in binding and cross-linking studies are described. The 125I-labeled toxin is specifically cross-linked to a receptor protein with an apparent Mr of 135,000. The stoichiometry between omega-conotoxin and nitrendipine binding sites in different chick tissues was determined. Skeletal muscle has a high concentration of [3H]nitrendipine binding sites (greater than 1000 fmol/mg) but no detectable omega-conotoxin sites (less than 7 fmol/mg). Brain microsomes have both binding sites, but omega-conotoxin targets are in excess. These results, combined with recent electrophysiological studies (E. W. McCleskey, A. P. Fox, D. Feldman, L. J. Cruz, B. M. Olivera, R. W. Tsien, and D. Yoshikami, unpublished results), define four types of Ca channels in chick tissues, N, T, Ln (omega sensitive), and Lm (omega insensitive), and are consistent with the hypothesis that the alpha-subunits of certain neuronal Ca2+ channels (Ln, N) are the molecular targets of omega-conotoxin GVIA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436655     DOI: 10.1021/bi00377a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  Metabolism and trafficking of N-type voltage-operated calcium channels in neurosecretory cells.

Authors:  E Sher; P Rosa; M Francolini; A Codignola; E Morlacchi; E Taverna; F Giovannini; A Brioschi; F Clementi; M W McEnery; M Passafaro
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

Review 2.  Calcium channels in cellular membranes.

Authors:  P G Kostyuk
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

Review 3.  Reconstitution of channel proteins from excitable cells in planar lipid bilayer membranes.

Authors:  M Montal
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

4.  Inhibition of central neurotransmitter release by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel.

Authors:  D J Dooley; A Lupp; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

Review 5.  Calcium channels: molecular pharmacology, structure and regulation.

Authors:  M M Hosey; M Lazdunski
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

6.  Inhibition of Escherichia coli chemotaxis by omega-conotoxin, a calcium ion channel blocker.

Authors:  L S Tisa; B M Olivera; J Adler
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

7.  omega-Grammotoxin blocks action-potential-induced Ca2+ influx and whole-cell Ca2+ current in rat dorsal-root ganglion neurons.

Authors:  T M Piser; R A Lampe; R A Keith; S A Thayer
Journal:  Pflugers Arch       Date:  1994-02       Impact factor: 3.657

8.  Binding and labeling of omega-conotoxin GVIA in crude membranes from subfractionated fractions and various areas of chick brain.

Authors:  S Ichida; T Wada; K Hashimoto; Y Kasamatsu; T Akimoto; M Tahara
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

9.  Possible involvement of both N- and L-type voltage-dependent Ca channels in adrenergic neurotransmission of canine saphenous veins in low Ca2+ plus tetraethylammonium medium.

Authors:  Y Takata; J Ozawa; H Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

10.  Effect of calcium antagonists (omega-conotoxin GVIA, verapamil, gallopamil, diltiazem) on bronchial smooth muscle contractions induced by soman.

Authors:  P Walday; E Fyllingen; P Aas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.